Resident Accomplishments

2024

  • King B, Lilly A, Cloonan J. Conquering Confusion: Could Metformin Reduce Dementia Risk?. Peer reviewed. iForumRx Commentary and Podcast. 
  • Cloonan, J. Gabelman, D. Borovicka, M. Ortiz, J. "Impact of Pharmacist Administration of Long-Acting Injectable Antipsychotics in Community Pharmacies." AAPP Annual Meeting in Orlando, Florida. 2024.
  • Cloonan, J. Gabelman, D. Borovicka, M. Ortiz, J. "Impact of Pharmacist Administration of Long-Acting Injectable Antipsychotics in Community Pharmacies." Peer reviewed. ACCP Virtual Poster Symposium. 2024.
  • Amber Lilly received the 2024 ACCP Virtual Poster Symposium Amb Care PRN First Place Trainee Poster Award
  • Amber Lilly received the 2024 Ohio College of Clinical Pharmacist Board of Pharmacy Specialties Award
  • Lilly A, King C, McNinch N, Trocchio D. Impact of Continuous Glucose Monitoring on Pharmacist Management of Type 2 Diabetes Mellitus. Peer reviewed. ACCP Virtual Poster Symposium. 2024.
  • King C, Lilly A.  "Best practices and rationale for expanding Medicaid access to continuous glucose monitoring."  J Manag Care Pharm.  2024;30(10-b):S40-S49.
  • King C, King B, Nagaraj T, et al. “Cost-effectiveness analysis of pharmacist-led diabetes management across primary care clinics.” Innov Pharm. 2024;15(3). doi.10.24926/iip.v15i3.6300 https://pubs.lib.umn.edu/index.php/innovations/article/view/6300

2023

  • King C, Anderson L, Cloonan J. “Changing the way patients access reproductive healthcare.” BCACP CE. ASHP Midyear Clinical Meeting. Anaheim, CA. December 2023.
  • King C, Anderson L, Cloonan J. “Changing the way patients access reproductive healthcare.” BCACP CE. ACCP Annual Meeting. Dallas, TX. November 2023.
  • King C, Lilly A. American College of Clinical Pharmacy Am Care PRN Seed Grant for Integration of continuous glucose monitors into primary care clinics within a large academic health system ($2000).
  • King B, Winar J, Ortiz J. How many patients can a pharmacist reasonably manage? Estimating an appropriate panel size. Peer reviewed. iForumRx Commentary and Podcast. 
  • Winar J, King B, Doycich E, et al. GLP1 Receptor Agonists: Safety and Efficacy Differences in a Real-World Population. Peer reviewed. ACCP Virtual Poster Symposium. 2023.
  • Ortiz, J. Valente, M. Gabelman, D. Gothard, D. Assessing the Impact of Medication Titration Velocity on Clinical Outcomes in Patients with Heart Failure with Reduced Ejection Fraction. Heart Failure Society of America Annual Meeting. Cleveland, OH. 2023.
  • Matta M, Ortiz J, Valente M, et al. “Comparison of Time to Guideline Directed Medical Therapy among Ischemic and Non-ischemic Cardiomyopathy.” Heart Failure Society of America Annual Meeting. Cleveland, OH. 2023.
  • Alawadhi Y, Ortiz J, Valente M, et al. Guideline Directed Medical Therapy Titration Rates: Impact on Renal Function, Blood Pressure, and Heart Failure Admissions in Patients with Heart Failure with Reduced Ejection Fraction. Heart Failure Society of America Annual Meeting. Cleveland, OH. 2023.
  • Dehaini H, Ortiz J, Valente M, et al. Does Duration of GDMT Up-titration Affect the percentage of Attained HFimpEF? Heart Failure Society of America Annual Meeting. Cleveland, OH. 2023.